Page last updated: 2024-09-04

torcetrapib and avasimibe

torcetrapib has been researched along with avasimibe in 1 studies

Compound Research Comparison

Studies
(torcetrapib)
Trials
(torcetrapib)
Recent Studies (post-2010)
(torcetrapib)
Studies
(avasimibe)
Trials
(avasimibe)
Recent Studies (post-2010) (avasimibe)
273288377630

Protein Interaction Comparison

ProteinTaxonomytorcetrapib (IC50)avasimibe (IC50)
Sterol O-acyltransferase 1Rattus norvegicus (Norway rat)0.5345
Sterol O-acyltransferase 2Homo sapiens (human)9.2
Sterol O-acyltransferase 1Homo sapiens (human)1.526
Sterol O-acyltransferase 1Mus musculus (house mouse)0.47
Acyl-CoA:cholesterol acyltransferase Oryctolagus cuniculus (rabbit)7.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdallah, M; Abi Rafeh, N; Bhat, T; El-Sayegh, S; Kalantar-Zadeh, K; Khoueiry, G; Lafferty, J; Raza, M; Saiful, F1

Reviews

1 review(s) available for torcetrapib and avasimibe

ArticleYear
High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.
    International urology and nephrology, 2014, Volume: 46, Issue:1

    Topics: Acetamides; Acetates; Acetyl-CoA C-Acetyltransferase; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Cholesterol; Cholesterol Ester Transfer Proteins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins, HDL; Niacin; PPAR alpha; Quinolines; Renal Insufficiency, Chronic; Sulfonamides; Sulfonic Acids; Uremia

2014